Elevation Oncology Ownership | Who Owns Elevation Oncology?
Elevation Oncology Ownership Summary
Elevation Oncology is owned by 11.46% institutional investors, 0.35% insiders, and 88.19% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 10.14% of ELEV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.76% of its assets in Elevation Oncology shares.
ELEV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Elevation Oncology | 11.46% | 0.35% | 88.19% |
Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Frazier life sciences management | 5.99M | 10.14% | $1.55M |
Tang capital management | 4.76M | 8.05% | $2.68M |
Blackrock funding, inc. /de | 3.16M | 5.35% | $1.78M |
Aisling capital management lp | 2.83M | 4.80% | $1.59M |
Vanguard group | 2.61M | 4.42% | $1.47M |
Blackrock | 2.49M | 4.22% | $6.72M |
Goldman sachs group | 1.65M | 2.79% | $929.26K |
Renaissance | 1.60M | 2.71% | $902.02K |
Morgan stanley | 1.27M | 2.16% | $3.44M |
Geode capital management | 1.16M | 1.96% | $651.36K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Aisling capital management lp | 2.83M | 0.56% | $1.59M |
Tang capital management | 4.76M | 0.18% | $2.68M |
Sphera funds management | 1.02M | 0.10% | $573.04K |
Frazier life sciences management | 5.99M | 0.07% | $1.55M |
Artal group | 1.01M | 0.07% | $2.74M |
Ikarian capital | 690.05K | 0.02% | $178.79K |
Palumbo wealth management | 69.11K | 0.01% | $38.88K |
Velan capital investment management lp | 45.00K | 0.01% | $11.66K |
Two sigma securities | 62.38K | 0.00% | $35.09K |
Boothbay fund management | 183.45K | 0.00% | $103.21K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 2.49M | 0.00% | 2.32M |
Morgan stanley | 1.27M | 0.00% | 1.25M |
Blackrock funding, inc. /de | 3.16M | - | 258.01K |
Deutsche bank ag\ | 188.77K | - | 159.75K |
Jpmorgan chase | 180.38K | - | 119.04K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Logos global management lp | - | - | -3.85M |
Farallon capital management | - | - | -3.53M |
Bvf inc/il | - | - | -2.97M |
Balyasny asset management | - | - | -2.48M |
Venbio partners | - | - | -2.43M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Wellington management group llp | 116.07K | 0.00% | 116.07K | $313.38K |
Two sigma securities | 62.38K | 0.00% | 62.38K | $35.09K |
Susquehanna group, llp | 37.92K | - | 37.92K | $21.34K |
Vanguard personalized indexing management | 20.21K | 0.00% | 20.21K | $11.37K |
Voya investment management | 18.48K | 0.00% | 18.48K | $49.89K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -11.00 |
Nisa investment advisors | -1.16K |
Macquarie group | -1.27K |
Amalgamated bank | -1.80K |
Mercer global advisors inc /adv | -10.03K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 4 | -94.44% | 6,773,820 | -83.05% | 11 | 0.25% | - | -100.00% | 1 | -92.31% |
Dec 31, 2024 | 71 | 2.90% | 33,979,478 | -26.03% | 57 | 0.95% | 39 | - | 13 | -23.53% |
Sep 30, 2024 | 69 | -14.81% | 45,936,801 | -11.86% | 77 | 1.00% | 39 | -25.00% | 17 | -19.05% |
Jun 30, 2024 | 81 | 26.56% | 52,117,516 | 18.46% | 88 | 1.02% | 52 | 1.96% | 21 | 133.33% |
Mar 31, 2024 | 64 | 106.45% | 43,997,469 | 70.21% | 92 | 2.50% | 51 | 628.57% | 9 | 28.57% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.64M | 2.76% | - |
iShares Russell 2000 ETF | 1.29M | 2.19% | 633.00 |
Aesculape SRI IC | 755.00K | 1.27% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 608.57K | 1.03% | - |
Fidelity Small Cap Index | 552.58K | 0.93% | 16.13K |
iShares Russell 2000 Growth ETF | 461.96K | 0.78% | - |
Vanguard US Momentum Factor ETF | 430.42K | 0.73% | 430.42K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 300.71K | 0.51% | - |
State St Russell Sm/Mid Cp® Indx SL Cl I | 300.71K | 0.51% | - |
Fidelity Extended Market Index | 287.51K | 0.49% | 3.50K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 25, 2022 | venBio Global Strategic Fund III, L.P. | - | Sell | $2.90M |
May 25, 2022 | Royston Aaron | Sell | $2.90M | |
Jun 29, 2021 | Qiming U.S. Healthcare Fund II, L.P. | - | Buy | $5.00M |
Jun 29, 2021 | Aisling Capital IV, LP | - | Buy | $3.00M |
Jun 29, 2021 | venBio Global Strategic Fund III, L.P. | - | Buy | $10.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
ELEV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools